NCT01463358

Brief Summary

Study Objective The purpose of this study is to evaluate the efficacy of bradycardia pacing with respect to patient symptoms in patients with bifascicular block and syncope of unexplained origin.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2005

Longer than P75 for not_applicable

Geographic Reach
1 country

12 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2005

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2011

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2011

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 27, 2011

Completed
4 months until next milestone

First Posted

Study publicly available on registry

November 1, 2011

Completed
9.5 years until next milestone

Results Posted

Study results publicly available

April 19, 2021

Completed
Last Updated

April 19, 2021

Status Verified

March 1, 2021

Enrollment Period

5.9 years

First QC Date

June 27, 2011

Results QC Date

January 4, 2021

Last Update Submit

March 23, 2021

Conditions

Keywords

SyncopeBifascicular blockBradycardia pacing

Outcome Measures

Primary Outcomes (1)

  • Combined Endpoint Defined as First Occurrence Among the Following Events 1)Syncope Episode of Any Origin; 2)Presyncopal Episode With Documented Cardioinhibitory Origin 3) Atrioventricular Block of Any Degree Associated With Patient Symptoms

    Number of participants experiencing syncope episodes, symptomatic pre-syncopal episodes associated with a device intervention (ventricular pacing) and symptomatic episodes associated with documentation of intermittent or permanent atrio-ventricular block

    2 years

Secondary Outcomes (2)

  • Occurrence of First Symptomatic Episode (Syncope or Pre-syncope), Independently From Origin.

    2 years

  • Atrial Fibrillation

    2 years

Study Arms (2)

DDI30

OTHER

Control group based only on backup pacing with lower rate 30 ppm

Device: DDD60 (INSIGNIA® pacing systems Guidant (Boston Scientific)

DDD60

ACTIVE COMPARATOR

Treatment arm based on full pacing support (60 Lower Rate)

Device: DDD60 (INSIGNIA® pacing systems Guidant (Boston Scientific)

Interventions

pacing in DDD60 is supposed to prevent events of syncope, presyncope of cardioinhibitory origin and symptom associated to av block

Also known as: INSIGNIA® pacing systems Guidant (Boston Scientific)
DDD60

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Evidence of Bifascicular block
  • At least one episode of syncope during last 6 months from the enrollment

You may not qualify if:

  • Patients with Brady-tachy syndrome that needs of pacemaker to prevent the symptomatic bradycardia o symptomatic tachycardia arrhythmia
  • Patients with vasovagal syndrome by positive TTT or carotid sinus syndrome
  • Patients with Chronic Atrial Fibrillation
  • Patients with Atrial Ventricular Block induces at EPS

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (12)

Ospedale Santa Maria Annunziata

Bagno a Ripoli, Italy

Location

Azienda Ospedaliera S. Sebastiano

Caserta, Italy

Location

Ospedale Valduce

Como, Italy

Location

Azienda Ospedaliera Osp. Maggiore

Crema, Italy

Location

Nuovo Ospedale S. Giovanni di Dio

Florence, Italy

Location

Ospedale Villa Scassi

Genova, Italy

Location

Ospedale Umberto I

Mestre, Italy

Location

Ospedale GB Grassi

Ostia - Roma, Italy

Location

Ospedale Civile G. De Lellis

Rieti, Italy

Location

Azienda Ospedaliera S. Filippo Neri

Roma, Italy

Location

Ospedale Sandro Pertini

Roma, Italy

Location

Policlinico Casilino

Roma, Italy

Location

Related Publications (2)

  • Brignole M, Donateo P, Tomaino M, Massa R, Iori M, Beiras X, Moya A, Kus T, Deharo JC, Giuli S, Gentili A, Sutton R; International Study on Syncope of Uncertain Etiology 3 (ISSUE-3) Investigators. Benefit of pacemaker therapy in patients with presumed neurally mediated syncope and documented asystole is greater when tilt test is negative: an analysis from the third International Study on Syncope of Uncertain Etiology (ISSUE-3). Circ Arrhythm Electrophysiol. 2014 Feb;7(1):10-6. doi: 10.1161/CIRCEP.113.001103. Epub 2013 Dec 12.

  • Santini M, Castro A, Giada F, Ricci R, Inama G, Gaggioli G, Calo L, Orazi S, Viscusi M, Chiodi L, Bartoletti A, Foglia-Manzillo G, Ammirati F, Loricchio ML, Pedrinazzi C, Turreni F, Gasparini G, Accardi F, Raciti G, Raviele A. Prevention of syncope through permanent cardiac pacing in patients with bifascicular block and syncope of unexplained origin: the PRESS study. Circ Arrhythm Electrophysiol. 2013 Feb;6(1):101-7. doi: 10.1161/CIRCEP.112.975102. Epub 2013 Feb 6.

MeSH Terms

Conditions

Syncope

Condition Hierarchy (Ancestors)

UnconsciousnessConsciousness DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Massimo Santini MD FESC FACC
Organization
Casa di Cura san Pio XI

Study Officials

  • Massimo Santini, MD,FESC,FACC

    Ospedale San Filippo Neri, Roma, Italy

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 27, 2011

First Posted

November 1, 2011

Study Start

March 1, 2005

Primary Completion

February 1, 2011

Study Completion

May 1, 2011

Last Updated

April 19, 2021

Results First Posted

April 19, 2021

Record last verified: 2021-03

Locations